How to Buy Cogent Biosciences Stock
Cogent Biosciences Inc
Cogent Biosciences, Inc. , a biotechnology company, focuses on developing precision therapies for genetically defined diseases.
Cogent Biosciences stock last closed at $6.02, up 0.17% from the previous day, and has decreased 44.16% in one year. It has underperformed other stocks in the Biotechnology industry by 0.22 percentage points. Cogent Biosciences stock is currently +64.03% from its 52-week low of $3.67, and -55.41% from its 52-week high of $13.50.
There are currently 103.91M shares of COGT outstanding. The market cap of COGT is $625.56M. In the past 24 hours, 912,164 COGT shares were traded.
How to Buy Cogent Biosciences Stock
Not sure how to invest in Cogent Biosciences stock? Here's how.
- Choose where to buy Cogent Biosciences stock: You need to pick a stock brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you decide where to buy Cogent Biosciences stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Fund your investment account: Choose your method of payment and add your info.
- Evaluate Cogent Biosciences stock: The Cogent Biosciences ticker symbol is COGT. Is Cogent Biosciences stock a good investment? Should you buy shares of COGT? How do COGT's underlying business fundamentals look? Do top analysts think Cogent Biosciences is a good buy? Why has COGT's stock price moved recently? (Hint: Our stock market research tools can help you evaluate if COGT is a good stock to buy).
- Make your COGT buy order: Decide if you will purchase COGT shares at the current market price or use a limit order to buy COGT shares at a given price.
- Get notifications regarding your investment in COGT: Create a watchlist to monitor your position in Cogent Biosciences stock.
Step 1: Choose where to buy Cogent Biosciences stock
You will need a brokerage account to access the NASDAQ market and buy COGT shares.
Our favorite brokerage: eToro
Based on our experience, eToro is the best place to buy stocks. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global markets: From Tech to Utilities, New York to Tokyo — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by creating an account with eToro now.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've chosen the best brokerage, it's time to fill out some personal info so you are able to invest in COGT stock today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to open a new brokerage account.
- Submit your information by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you have filled out your info on our top ranked stock trading app, you need to deposit funds:
Watch the walkthrough below for more details depositing money into your investment account.
Step 4: Evaluate Cogent Biosciences stock
After you have selected the best place to buy Cogent Biosciences stock, it's critical to analyze their stock before you invest, so you can comprehend the risk and upside.
Cogent Biosciences stock at a glance
COGT Zen Score
WallStreetZen was built to help part-time investors perform more in-depth fundamental analysis in less time.
You can view all of the due diligence checks on COGT's stock page.
Is COGT stock undervalued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge COGT's fair value.
Using relative valuations ratios:
- COGT may be undervalued based on its P/B ratio of 2.43x, relative to Biotechnology industry P/B ratio of 5.85x
You can do more valuation analysis on COGT's stock here.
A quick look at COGT Financials
Positive Health Checks:
- COGT has cash burn of 156420000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the COGT balance sheet.
- There are more short-term assets than long-term liabilities on the COGT balance sheet.
- Total COGT debt is lower than 5 years ago, relative to shareholder equity.
- COGT has a low debt to equity ratio of 0.22.
Negative Health Checks:
- COGT has $265.71M in cash and short term investments. This is not enough to cover its annual cash burn of $156.42M.
Do analysts think it's a good time to buy Cogent Biosciences stock
Out of 6 Wall Street analysts who give forecasts on COGT, the consensus analyst rating on COGT is a Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
Most Recent COGT Analyst Ratings
Robert Burns, a bottom 1% analyst from HC Wainwright & Co. maintains COGT with a buy rating and lowers their COGT price target from $27.00 to $13.00, on Dec 15, 2023.
You can dig deeper into what analysts are saying on the Cogent Biosciences stock forecast page.
Metrics for Advanced COGT Traders
COGT Revenue
Last year, COGT revenue was $0.00. Over the past 5 year, COGT's revenue has gone up by -100% per year. This was slower than the Biotechnology industry average of 28.56%.
You can research COGT's earnings and revenue performance here.
What are COGT executives and large shareholders up to?
Over the last year, executives and large shareholders at COGT have bought more shares than they have sold.
Fairmount Funds Management LLC, 10% Owner of COGT, was the latest COGT insider to buy. They bought $8,749,995.00 worth of COGT shares on Feb 16, 2024.
Learn more about who owns COGT shares here.
Can I rely on COGT as an income stream?
No, Cogent Biosciences doesn't provide an income stream by paying out dividends.
What others are saying about COGT
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Make your COGT buy order
There are two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are generally sufficient. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a given dollar amount, use a limit order.
Click the Open button and your broker will place your order.
If you need additional help investing in stocks on eToro, click the how to video below:
Step 6: Get notifications regarding your investment in COGT
Now that you own some COGT stock, you'll want to keep up with your stock purchase.
Start a watchlist to get alerted to the latest events about your COGT stock.
COGT Feed
How to Buy Stock in Cogent Biosciences
To reiterate, here are the 6 steps you need to take to buy Cogent Biosciences stock right now:
- Choose where to buy Cogent Biosciences stock
- Sign up for a brokerage account
- Fund your investment account
- Evaluate Cogent Biosciences stock
- Make your COGT buy order
- Get notifications regarding your investment in COGT
If you are looking for a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get notifications regarding your investment in Cogent Biosciences, click below.
Other Content You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.